Chickenpox
A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)
Drugs by status
Approved for this indication (2)
Phase 4 trials (10)
- gelatin
- hepatitis b vaccine (recombinant)
- hepatitis a vaccine, inactivated
- attenuated measles vaccine - Edmonston strain
- inactivated influenza vaccine
- live attenuated chimeric japanese encephalitis vaccine
- live attenuated varicella vaccine
- measles, mumps, rubella, varicella vaccine
- measles, mumps, and rubella vaccine
- inactivated SARS-Cov-2 vaccine
Phase 3 trials (18)
- sorivudine
- aciclovir
- albumin (Human)
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- netivudine
- famciclovir
- pneumococcal 13-valent conjugate vaccine
- Measles, Mumps and Rubella Vaccine, Live
- live, attenuated herpes zoster vaccine
- inactivated japanese encephalitis vaccine
- Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant)
- pneumococcal 7-valent conjugate vaccine
- v221
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- varicella zoster virus glycoprotein e antigen
- 15-valent pneumococcal conjugate vaccine
- 20-valent pneumococcal conjugate vaccine
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (26)
- AstraZeneca
- Merck
- Sanofi
- Sanofi-Aventis
- Changchun Changsheng Life Science and Technology Co., Ltd.
- Changchun Keygen Biological Products Co., Ltd.
- GlaxoSmithKline
- National Institute of Allergy and Infectious Diseases (NIAID)
- Cairo University
- Chulalongkorn University
- Stanford University
- The Guenther Dermatology Research Centre
- The HIV Netherlands Australia Thailand Research Collaboration
- University of Toronto
- University of Colorado, Denver
- University of Nairobi
- Vietnam Military Medical University
- University of the Witwatersrand
- Government of China
- Innovaderm
- University of Colorado
- China National Biotec Group Co., Ltd
- Canadian Institutes of Health Research (CIHR)
- Kenyan AIDS Vaccine Initiative
- Centers for Disease Control and Prevention (CDC)
- Vabiotech
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (4)